Developmental Core (Core B) The mission of the Development Core is to operationalize the Scientific Agenda of the UAB CFAR through strategic investment, targeted recruitment, and to ensure the development of early investigators in HIV research. This is accomplished through provision of direct financial support, partnerships with Departmental leaders on campus, and through directed mentorship and linkage to UAB CFAR services and collaborative investigators for emerging scientists. The Developmental Core acts as a mentoring and research integration support system serving UAB investigators engaged in HIV/AIDS research, with a particular emphasis on supporting early stage and underrepresented minority investigators. Implementation of the UAB CFAR vision has been and remains key to the dynamic and vibrant research environment that has made it one of the most prolific contributors to HIV research for almost 30 years. The Developmental Core steers the UAB CFAR in promoting basic, translational, clinical, and community-engaged research and will continue to do so through 4 aims.
The first aim will mentor early career UAB CFAR faculty members to compete and cope with the rigors of academic research. The core will provide targeted mentoring to junior faculty via faculty development programs and linkage to mentors specific to their research area and career ambitions. We will also provide linkage to collaborators with the UAB HIV Network affiliations and assistance with grant writing and review. Mentorship training is enhanced via our collaboration with the NIH funded UAB Center for Clinical and Translational Science and UAB?s Graduate School.
The second aim will administer the highly successful CFAR Developmental Grant Program. As our investment in young investigators impacts future HIV research efforts at UAB, the program will be aligned with the NIH?s HIV/AIDS Research initiatives and with an emphasis placed on the career development of young investigators and underrepresented minority investigators.
The third aim will foster a collaborative research environment through the interdisciplinary research groups (IRGs) and our scientific working group (SWG). Working on a common topic, via the IRG or SWG mechanism, is an efficient strategy to promote the generation of new scientific ideas and the development of new areas of collaborative or independent research. We will work with the IRGs as well as our newly formed Ending HIV in Alabama SWG to identify collaborative opportunities for senior and junior investigators, and to facilitate mentoring and academic development of young investigators.
The final aim will coordinate UAB CFAR resources in support of recruited investigators who fit the CFAR Strategic Plan. During this past funding period, we successfully recruited new faculty into the HIV research arena, and increased the ethnic and gender diversity of our team of investigators. We have intensified our efforts to ensure that all recruits become successful investigators, and that they are supported by the breadth of CFAR services available for their research and career development.
These aims have been formulated in large part from our experiences, and we are confident that they will ensure the continuation of UAB?s strong HIV research base.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI027767-32
Application #
9930529
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2020-06-01
Budget End
2021-05-31
Support Year
32
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of Alabama Birmingham
Department
Type
DUNS #
063690705
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Mai, Uyen; Mirarab, Siavash (2018) TreeShrink: fast and accurate detection of outlier long branches in collections of phylogenetic trees. BMC Genomics 19:272
Tomalka, Amanda G; Resto-Garay, Ivelisse; Campbell, Kerry S et al. (2018) In vitro Evidence That Combination Therapy With CD16-Bearing NK-92 Cells and FDA-Approved Alefacept Can Selectively Target the Latent HIV Reservoir in CD4+ CD2hi Memory T Cells. Front Immunol 9:2552
Ram, Daniel R; Manickam, Cordelia; Hueber, Brady et al. (2018) Tracking KLRC2 (NKG2C)+ memory-like NK cells in SIV+ and rhCMV+ rhesus macaques. PLoS Pathog 14:e1007104
AIDS-defining Cancer Project Working Group of IeDEA, COHERE in EuroCoord (2018) Non-Hodgkin lymphoma risk in adults living with HIV across five continents. AIDS 32:2777-2786
Rice, Whitney S; Logie, Carmen H; Napoles, Tessa M et al. (2018) Perceptions of intersectional stigma among diverse women living with HIV in the United States. Soc Sci Med 208:9-17
Elion, Richard A; Althoff, Keri N; Zhang, Jinbing et al. (2018) Recent Abacavir Use Increases Risk of Type 1 and Type 2 Myocardial Infarctions Among Adults With HIV. J Acquir Immune Defic Syndr 78:62-72
Fredericksen, R J; Gibbons, L; Brown, S et al. (2018) Medication understanding among patients living with multiple chronic conditions: Implications for patient-reported measures of adherence. Res Social Adm Pharm 14:540-544
Stoll, Matthew L; Weiss, Pamela F; Weiss, Jennifer E et al. (2018) Age and fecal microbial strain-specific differences in patients with spondyloarthritis. Arthritis Res Ther 20:14
Subramaniam, Akila; Van Der Pol, William J; Ptacek, Travis et al. (2018) Midtrimester microbial DNA variations in maternal serum of women who experience spontaneous preterm birth. J Matern Fetal Neonatal Med :1-9
Kay, Emma S; Rice, Whitney S; Crockett, Kaylee B et al. (2018) Experienced HIV-Related Stigma in Health Care and Community Settings: Mediated Associations With Psychosocial and Health Outcomes. J Acquir Immune Defic Syndr 77:257-263

Showing the most recent 10 out of 955 publications